Tuesday, November 17, 2026Moscow
Society

Promomed and Kurchatov Institute join forces to develop new drugs

Promomed and Kurchatov Institute have agreed on cooperation in the field of innovative medicines and medical technologies

Published
Promomed and Kurchatov Institute join forces to develop new drugs

Promomed and Kurchatov Institute have agreed on cooperation in the field of innovative medicines and medical technologies. The agreement signed at the Kurchatov Genomic Forum provides for the use of megascience research facilities and the infrastructure of the Kurchatov Medical Primatology Complex.

Signatures under the document were put by the President of the Research Center “Kurchatov Institute” Mikhail Kovalchuk and the Chairman of the Board of Directors of “Promomed” Peter Bely. The partners plan to link the capabilities of fundamental science with the tasks of pharmaceutical development. Among the areas of joint work are the creation of medicinal substances, radiopharmaceutics, the study of genetic mechanisms and the search for approaches to the treatment of age-associated diseases.

How Studying Molecules Helps Create Drugs

One of the tools of future cooperation is X-ray structural analysis. This method allows studying the spatial structure of molecules and obtaining data necessary for further work on drug compounds.

As Mikhail Kovalchuk noted, high-tech scientific infrastructure should be used to create new technologies, including those aimed at improving the quality and life expectancy. Structural research helps scientists at different stages of development: when choosing promising molecules, studying their properties and finding opportunities for optimization.

For Promomed, the agreement expands research opportunities for new drugs. The company has its own R&D center and production site, Biochemistry plant. This structure allows you to develop projects from a scientific idea and the creation of a molecule to the release of a drug. Cooperation with the Kurchatov Institute should complement this system with tools for solving complex scientific problems.

From scientific hypothesis to preclinical research n

A separate place in the partnership is occupied by the Kurchatov Medical Primatology Complex. Its infrastructure is planned to be used to test scientific hypotheses and study prototypes of drugs at the preclinical stage.

Among the stated directions is the study of potential approaches to preserving cognitive functions and slowing down the aging process. The joint work involves the use of modern methods of visualization, structural analysis and neurophysiological monitoring. The obtained data should help researchers assess the prospects of molecules and the validity of their further study.

Drug development requires consistent verification of compound properties, safety and efficacy. The joint research is designed to provide a scientific basis for the selection of promising compounds and their further progress to clinical trials.

Promomed develops a portfolio of drugs in the field of endocrinology, oncology, neurology, autoimmune and infectious diseases, as well as in other therapeutic areas. The partnership with the Kurchatov Institute should strengthen the research base of this work and accelerate the transition from scientific problems to practical solutions.

Source: Московский комсомолец ↗

Share

More on This Story

The son of Dmitry Gudkov committed suicide
SocietyThe son of Dmitry Gudkov committed suicide

Ivan Gudkov, the son of oppositionist Dmitry Gudkov and his first wife, Sophia Kapkova, committed suicide. Ksenia Sobchak said that he reported on the difficulties of emigration

Яна Соловьева
In the fighter MMA “Nikarho” shot from the trauma in the center of Vladikavkaz
SocietyIn the fighter MMA “Nikarho” shot from the trauma in the center of Vladikavkaz

In the center of Vladikavkaz, a man was injured as a result of shooting from a traumatic pistol, the Ministry of Internal Affairs for North Ossetia reports.

Виктория Хабарова, Александра Озерова
PCT reported 23 complaints of sick tourists from a hotel in Turkey
SocietyPCT reported 23 complaints of sick tourists from a hotel in Turkey

Since August, insurance companies have recorded 23 appeals from tourists vacationing in the Turkish hotel Bosphorus Sorgun, with similar complaints of poor health, told RBC in the press service of the Russian Union of Travel Industry (PCT).

Евгения Сорокина, Виктория Хабарова
The EIA Briefing

Keep reading, every morning.

The stories that matter, chosen by our editors and in your inbox before 7 a.m. — every weekday.

No spam. Unsubscribe anytime.